Effect of miR-340 on gastric cancer cell proliferation and apoptosis

Xu Hou1, Haiquan Qiao1

  • 1Department of General Surgery, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.

Insights

MicroRNA-340 (miR-340) is overexpressed in gastric cancer, promoting tumor cell growth and reducing apoptosis. This finding offers insights into gastric cancer progression and potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric cancer pathogenesis involves complex genetic alterations and abnormal gene expression.
  • MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
  • Understanding the specific roles of miRNAs like miR-340 is vital for potential clinical applications.

Purpose of the Study:

  • To investigate the effect of miR-340 on the proliferation and apoptosis of human gastric cancer cell lines (SGC-7901 and BGG823).
  • To provide theoretical and experimental evidence for the potential clinical application of targeting miR-340 in gastric cancer.

Main Methods:

  • Gene expression screening using array technology.
  • Quantitative Polymerase Chain Reaction (Q-PCR) for gene expression analysis in tissues and cells.
  • MTT and colony formation assays to assess cell proliferation.
  • Flow cytometry and Annexin V/PI staining for cell cycle and apoptosis analysis.

Main Results:

  • Q-PCR confirmed significant overexpression of miR-340 in gastric cancer tissues compared to normal controls (P < 0.01).
  • Overexpression of miR-340 promoted proliferation in SGC-7901 and BGG823 cells, evidenced by MTT and colony formation assays.
  • Cell cycle analysis and Annexin V/PI staining indicated that miR-340 overexpression reduced cell apoptosis, with decreased apoptotic rates observed.

Conclusions:

  • MiR-340 overexpression effectively promotes gastric cancer cell growth.
  • MiR-340 plays a role in inhibiting apoptosis in gastric cancer cells.
  • These findings highlight miR-340 as a potential therapeutic target for gastric cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K